Lipid nanoparticle structure and delivery route during pregnancy dictate mRNA potency, immunogenicity, and maternal and fetal outcomes
Proceedings of the National Academy of Sciences · 12.03.2024 · 121 (11)
DOI: 10.1073/pnas.2307810121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 04.03.2024. Verfasst von Namit Chaudhary und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213. Hauptthemen laut MEDLINE: Endothelial Cells, Fetus, Liposomes, Nanoparticles. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, HHS | NIH | Office of Extramural Research, National Institutes of Health, National Science Foundation.
Abstract (Originalsprache)
Treating pregnancy-related disorders is exceptionally challenging because the threat of maternal and/or fetal toxicity discourages the use of existing medications and hinders new drug development. One potential solution is the use of lipid nanoparticle (LNP) RNA therapies, given their proven efficacy, tolerability, and lack of fetal accumulation. Here, we describe LNPs for efficacious mRNA delivery to maternal organs in pregnant mice via several routes of administration. In the placenta, our lead LNP transfected trophoblasts, endothelial cells, and immune cells, with efficacy being structurally dependent on the ionizable lipid polyamine headgroup. Next, we show that LNP-induced maternal inflammatory responses affect mRNA expression in the maternal compartment and hinder neonatal development. Specifically, pro-inflammatory LNP structures and routes of administration curtailed efficacy in maternal lymphoid organs in an IL-1β-dependent manner. Further, immunogenic LNPs provoked the infiltration of adaptive immune cells into the placenta and restricted pup growth after birth. Together, our results provide mechanism-based structural guidance on the design of potent LNPs for safe use during pregnancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213.
- Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213.
- Mellon Institute Centralized Vivarium, Carnegie Mellon University, Pittsburgh, PA 15213.
- Department of Obstetrics, Gynecology and Reproductive Sciences, Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, PA 15213.
ORCID-Profile: Alexandra N Newby, Mariah L Arral, Saigopalakrishna S Yerneni, Daria M Strelkova Petersen, Catalina Montoya, Julie S Kim, Angela Malaney, Yoel Sadovsky, Kathryn A Whitehead
Förderung
- NICHD NIH HHS
- HHS | NIH | Office of Extramural Research, National Institutes of Health
- National Science Foundation
Zitieren
APA
Chaudhary, N., Newby, A. N., Arral, M. L., Yerneni, S. S., LoPresti, S. T., Doerfler, R., Petersen, D. M. S., Montoya, C., Kim, J. S., Fox, B., Coon, T., Malaney, A., Sadovsky, Y., & Whitehead, K. A. (2024). Lipid nanoparticle structure and delivery route during pregnancy dictate mRNA potency, immunogenicity, and maternal and fetal outcomes. Proceedings of the National Academy of Sciences, 121(11). https://doi.org/10.1073/pnas.2307810121
Vancouver
Chaudhary N, Newby AN, Arral ML, Yerneni SS, LoPresti ST, Doerfler R, et al. Lipid nanoparticle structure and delivery route during pregnancy dictate mRNA potency, immunogenicity, and maternal and fetal outcomes. Proceedings of the National Academy of Sciences. 2024;121(11). doi:10.1073/pnas.2307810121
BibTeX
@article{Chaudhary2024,
author = {Chaudhary, Namit and Newby, Alexandra N and Arral, Mariah L and Yerneni, Saigopalakrishna S and LoPresti, Samuel T and Doerfler, Rose and Petersen, Daria M Strelkova and Montoya, Catalina and Kim, Julie S and Fox, Bethany and Coon, Tiffany and Malaney, Angela and Sadovsky, Yoel and Whitehead, Kathryn A},
title = {Lipid nanoparticle structure and delivery route during pregnancy dictate mRNA potency, immunogenicity, and maternal and fetal outcomes},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {11},
doi = {10.1073/pnas.2307810121}
}
EUVIMED